Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nutriband Inc. - Common Stock
(NQ:
NTRB
)
6.910
-0.020 (-0.29%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nutriband Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference
June 03, 2025
From
Nutriband Inc.
Via
GlobeNewswire
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Posts Record Q1 Revenue, Advances AVERSA Fentanyl Development
June 02, 2025
Via
Investor Brand Network
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl
June 02, 2025
From
Nutriband Inc.
Via
GlobeNewswire
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) CEO Highlights Transdermal Pain Solution on BioMedWire Podcast
May 27, 2025
Via
Investor Brand Network
Nutriband Inc. (NASDAQ: NTRB) Charts Path to Commercialization
May 22, 2025
Via
Investor Brand Network
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Strengthens Pharma Footprint Through Key Alliances
May 15, 2025
Via
Investor Brand Network
Topics
Artificial Intelligence
Nutriband Inc. (NASDAQ: NTRB) Pioneers Innovative Approach to Opioid Crisis with Game-Changing Transdermal Patch
May 13, 2025
Via
Investor Brand Network
Nutriband Inc. (NASDAQ: NTRB) Innovating Abuse-Deterrent Drug Delivery in a Shifting Opioid Landscape
May 09, 2025
Via
Investor Brand Network
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 30, 2025
Via
Benzinga
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) CEO Issues Shareholder Letter Highlighting 2024 Milestones and 2025 Commercialization Goals
April 30, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Nutriband Inc. (NASDAQ: NTRB) Leadership Team: Driving Innovation and Shaping the Future of Global Healthcare
April 30, 2025
Via
Investor Brand Network
Nutriband CEO Publishes Letter to Shareholders
April 30, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Inc. (NASDAQ: NTRB) Solution To Fentanyl Abuse Could Translate To $200 Million In Peak Revenue
April 30, 2025
Via
AB Newswire
Topics
Intellectual Property
Nutriband Inc (NASDAQ: NTRB) Solution To Fentanyl Abuse Could Translate To $200 Million In Peak Revenue
April 30, 2025
Nutriband Inc (NASDAQ: NTRB) Solution To Fentanyl Abuse Could Translate To $200 Million In Peak Revenue
Via
News Direct
Topics
Intellectual Property
BioMedNewsBreaks — Why Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’
April 25, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Nutriband Inc. (NASDAQ: NTRB): Building a Moat Around Abuse-Deterrent Drug Delivery
April 22, 2025
Via
Investor Brand Network
Topics
Intellectual Property
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) CEO Named EY Entrepreneur of the Year 2025 Finalist in Established Category
April 17, 2025
Via
Investor Brand Network
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures Patent in Macao for AVERSA Abuse-Deterrent Technology
April 11, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology
April 11, 2025
Nutriband granted patent protecting its AVERSA abuse deterrent platform technology in Macao, a Special Administrative Region of the People’s Republic of China
From
Nutriband Inc.
Via
GlobeNewswire
UPDATE – Nutriband Signs Associate Partnership with Charlotte FC
April 04, 2025
From
Nutriband Inc.
Via
GlobeNewswire
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Signs Partnership Deal With Charlotte FC to Boost Brand Visibility
April 04, 2025
Via
Investor Brand Network
Topics
Artificial Intelligence
Nutriband Signs Partnership Agreement with Charlotte FC
April 04, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Stock Market Indices Suffer Significant Trend Change Following Friday's Session
February 21, 2025
In this video, I review the market warnings I've shared over the past three weeks and how Friday's session confirmed negative divergences across key metrics signaling weakness.
Via
Talk Markets
Topics
ETFs
Stocks / Equities
Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.
February 21, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
February 13, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board
February 11, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™
February 07, 2025
The AVERSA™ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents already issued in 46 countries including the United States, Europe,...
From
Nutriband Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 07, 2025
Via
Benzinga
On Friday, there are stocks with unusual volume. Let's take a look.
January 24, 2025
These stocks have an unusual volume in today's session
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 22, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today